Compounds > acebutolol
Page last updated: 2024-10-21

acebutolol and Migraine Disorders

acebutolol has been researched along with Migraine Disorders in 2 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouvenot, G1
Escande, M1
Jouve, R1
Delboy, C1
Nanda, RN1
Johnson, RH1
Gray, J1
Keogh, HJ1
Melville, ID1

Trials

1 trial available for acebutolol and Migraine Disorders

ArticleYear
A double blind trial of acebutolol for migraine prophylaxis.
    Headache, 1978, Volume: 18, Issue:1

    Topics: Acebutolol; Clinical Trials as Topic; Humans; Migraine Disorders

1978

Other Studies

1 other study available for acebutolol and Migraine Disorders

ArticleYear
[Beta blockaders and general pathology].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1977, Mar-09, Volume: 53, Issue:10

    Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Female; Humans; Hypercalcemia; Hyperglycemia; Hypog

1977